ACE and heart failure: This is generally achieved either by inhibition ofangiotensin converting enzyme (ACE) or by the use of AT1 receptorantagonists (ARBs) although there is some evidence based on meta-analysis ofclinical trials that ACE inhibition is more effective than ARBs in reducingmortality in heart failure patients [346].